 effect dipyridamol persantin blood flow patenc aortocoronari vein bypass graft effect dipyridamol patient undergo coronari bypass surgeri dipyridamol mg day mg/kg bodi i.v mg year placebo studi patient dipyridamol placebo cardiovascular and/or cerebrovascular event need anticoagul treatment reason withdraw dipyridamol placebo group logist regress analysi risk factor graft patenc signific relat coronari blood flow posit trend treatment vein graft blood flow bypass surgeri patient dipyridamol group occlus rate vessel perop blood flow ml/min vein-margin vein-dext vein-diagon dipyridamol coronari blood flow graft patenc coronari bypass surgeri